New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that ultrasound-detected salivary gland abnormalities in primary Sjögren’s become more severe over time and that the slow-to-progress disease likely starts long before it is first detected.
J&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contract – Pharmaceutical Technology
J&J has reached several deals with pharma companies permitting biosimilar commercialisation after Stelara’s patent expired in July 2024. Image credit: Shutterstock/ Michael Vi. Johnson &
February 25, 2025